FDA Brief

Company record

Advanced Pharmaceutical Technology

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Advanced Pharmaceutical Technology.

Warning letters

  1. Advanced Pharmaceutical Technology

    FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.

    High risk

Recalls

ReportedClassFirmProduct and reason
Jan 21 Class II Advanced Pharmaceutical Technology, Inc.
Drug
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.